The significant improvement in adjusted EBITDA guidance and positive H1 operating cash flow signal a potential inflection point. Monitor Q3 results for continued cash flow improvement and whether the DHA prime contractor designation materializes, which could be a major catalyst. The steep YoY revenue decline warrants caution, but the trajectory of losses narrowing toward breakeven is a positive sign for the restructuring story.
Price Chart
Executive Summary
Amwell Q2 2026 revenue of $52.0M was at the top end of guidance, but total revenue declined 26.6% YoY from $70.9M. Net loss improved to ($9.6M) from ($19.5M) a year ago, and adjusted EBITDA improved to ($1.2M) from ($4.7M). The company raised the low end of its full-year revenue guidance to $200-205M and significantly improved its adjusted EBITDA outlook to ($9)-($7)M, while reiterating its goal of positive cash flow from operations in Q4 2026. The sequential improvement in losses and cash flow trajectory is notable, but the steep YoY revenue decline keeps the overall picture mixed.
Key Financial Metrics
Key Facts
- Q2 2026 total revenue of $52.0M, at the top end of guidance ($48-52M), down 26.6% YoY from $70.9M.
- Subscription revenue reached $25.7M, approaching half of total revenue.
- GAAP net loss improved to ($9.6M) from ($19.5M) YoY; adjusted EBITDA improved to ($1.2M) from ($4.7M) YoY.
- Full-year 2026 revenue guidance raised at the low end to $200-205M (from $195-205M); adjusted EBITDA guidance improved to ($9)-($7)M (from ($16)-($12)M).
- Operating cash flow was positive $9.7M in H1 2026 vs negative ($29.8M) in H1 2025.
- Company reiterated objective of positive cash flow from operations in Q4 2026.
Financial Impact
Revenue decline of $18.9M YoY (-26.6%) in Q2; net loss improved by $9.9M YoY; adjusted EBITDA improved by $3.5M YoY
Risk Factors
- Revenue continues to decline steeply YoY (-26.6%), driven by the divestiture of the APC business and lower AMG visit revenue.
- DHA relationship continuation beyond Q3 2026 with comparable financial terms is uncertain.
- Company remains unprofitable with negative adjusted EBITDA, though improving.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001393584-26-000016 |
| Document: amwl-20260804.htm | 0001393584-26-000016 |
| Document: 0001393584-26-000016-index-headers.html | 0001393584-26-000016 |
| Document: 0001393584-26-000016-index.html | 0001393584-26-000016 |
| Document: 0001393584-26-000016.txt | 0001393584-26-000016 |
| 8-K Data (Synthetic) | 0001393584-26-000016 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 4w ago | Insider Cluster | $13.25 $12.39 | ▼ −6.49% | ▼ −5.30% | $12.82 (−3.25%) |
Aug 4, 2026 8w ago | 8-K | $13.02 $12.83 | ▼ −1.46% | ▼ −0.86% | $12.82 (−1.54%) |
Jul 1, 2026 13w ago | 144 | $9.25 $10.84 | ▲ +17.19% | ▲ +17.60% | $12.82 (+38.59%) |
Jul 1, 2026 13w ago | Insider Cluster | $9.37 $10.77 | ▲ +14.94% | ▲ +17.13% | $12.82 (+36.82%) |
Jun 9, 2026 16w ago | DEFA14A | $8.50 $8.99 | ▲ +5.76% | ▲ +4.32% | $12.82 (+50.82%) |
Jun 3, 2026 17w ago | Insider Cluster | $8.65 $9.25 | ▲ +6.92% | ▲ +8.55% | $12.82 (+48.19%) |
Jun 1, 2026 17w ago | 144 | $8.35 $9.37 | ▲ +12.20% | ▲ +14.02% | $12.82 (+53.51%) |
May 18, 2026 19w ago | Press Release | $7.60 $8.69 | ▲ +14.33% | ▲ +12.14% | $12.82 (+68.66%) |
May 12, 2026 20w ago | 8-K | $7.69 $8.42 | ▲ +9.48% | ▲ +11.21% | $12.82 (+66.69%) |
May 5, 2026 21w ago | 8-K | $6.99 $8.46 | ▲ +21.01% | ▲ +18.23% | $12.82 (+83.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access